CHEMOTHERAPY INTENSITY AND TOXICITY AMONG BLACK AND WHITE WOMEN WITH ADVANCED AND RECURRENT ENDOMETRIAL CANCER: A GYNECOLOGIC ONCOLOGY GROUP STUDY

Por Farley, John H., Tian, Chunqiao, Rose, G. Scott, Brown, Carol L., Birrer, Michael, Risinger, John I, Thigpen, J. Tate, Fleming, Gini F., Gallion, Holly H., Maxwell, G. Larry
Publicado em 2010

Familial Site-specific Ovarian Cancer Is Linked to BRCA1 on 17q12-21

Por Steichen-Gersdorf, Elisabeth, Gallion, Holly H., Ford, Deborah, Girodet, Catherine, Easton, Douglas F., DiCioccio, Richard A., Evans, Gareth, Ponder, Margaret A., Pye, Carole, Mazoyer, Sylvie, Noguchi, Tetsuro, Karengueven, Fabienne, Sobol, Hagay, Hardouin, A., Bignon, Yves-Jean, Piver, M. Steven, Smith, Simon A., Ponder, Bruce A. J.
Publicado em 1994

An Evaluation of Genetic Heterogeneity in 145 Breast-Ovarian Cancer Families

Por Narod, Steven A., Ford, Deborah, Devilee, Peter, Barkardottir, Rosa B., Lynch, Henry T., Smith, Simon A., Ponder, Bruce A. J., Weber, Barbara L., Garber, Judy E., Birch, Jill M., Cornelis, Renee S., Kelsell, David P., Spurr, Nigel K., Smyth, Elizabeth, Haites, Neva, Sobol, Hagay, Bignon, Yves-Jean, Chang-Claude, Jenny, Hamann, Ute, Lindblom, Annika, Borg, Ake, Piver, M. Steven, Gallion, Holly H., Struewing, Jeffrey P., Whittemore, Alice, Tonin, Patricia, Goldgar, David E., Easton, Douglas F.
Publicado em 1995